Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.80%
1,094.09
-20.05
-1.80%
—1,114.141,119.391,121.191,093.68——
SIXC
Communications
SIXC
Communications
SIXC
-0.15%
612.67
-0.93
-0.15%
—613.60613.60617.80611.65——
SIXE
Energy
SIXE
Energy
SIXE
-1.90%
1,175.78
-22.78
-1.90%
—1,198.561,188.461,188.461,159.56——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.69%
1,754.32
-30.13
-1.69%
—1,784.451,788.951,792.831,749.89——
SIXM
Financials
SIXM
Financials
SIXM
-0.55%
635.29
-3.50
-0.55%
—638.79638.37641.72633.76——
SIXR
Staples
SIXR
Staples
SIXR
-0.09%
849.75
-0.75
-0.09%
—850.50848.90851.07839.52——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.84%
217.85
-1.84
-0.84%
—219.69219.69219.69216.89——
SIXT
Technology
SIXT
Technology
SIXT
-0.26%
3,415.17
-9.02
-0.26%
—3,424.193,429.183,463.333,398.08——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.38%
913.01
-12.75
-1.38%
—925.76922.77923.99911.33——
SIXV
Health care
SIXV
Health care
SIXV
-0.67%
1,459.57
-9.83
-0.67%
—1,469.401,468.961,473.181,457.86——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.29%
2,417.54
-7.08
-0.29%
—2,424.622,438.232,446.632,412.48——
GBY:FRA
Sangamo Therapeutics Inc
â‚Ĵ0.066
-49.58%
(-0.065) 1D
May 7, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GBY...
Open
â‚Ĵ0.06
High
â‚Ĵ0.07
Low
â‚Ĵ0.06
Mkt. cap
46.15M
Avg. vol.
545.00
Volume
500.00
52-wk high
â‚Ĵ0.65
52-wk low
â‚Ĵ0.04
No. of employees
142
News stories
From sources across the web
Profile
Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases. Wikipedia
About Sangamo Therapeutics Inc
CEOSandy Macrae
Employees142
Founded1995
HeadquartersRichmond, California, United States
SectorBiotechnology
Websitesangamo.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
6.44M
18.31M
581.00K
14.23M
Cost of goods sold
24.81M
27.08M
28.14M
31.44M
Cost of revenue
24.81M
27.08M
28.14M
31.44M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.06M
9.08M
7.99M
7.76M
Operating expense
10.06M
9.08M
7.99M
7.76M
Total operating expenses
34.86M
36.16M
36.13M
39.20M
Operating income
-28.43M
-17.86M
-35.55M
-24.97M
Other non operating income
-
-2.49M
207.00K
-21.00K
EBT including unusual items
-30.48M
-19.96M
-35.09M
-37.97M
EBT excluding unusual items
-29.28M
-19.96M
-35.09M
-24.74M
Income tax expense
119.00K
27.00K
-161.00K
-553.00K
Effective tax rate
-0.39%
-0.14%
0.46%
1.46%
Other operating expenses
-
-
-
-
Net income
-30.60M
-19.99M
-34.93M
-37.42M
Net profit margin
-475.33%
-109.18%
-6,012.05%
-263.00%
Earnings per share
-0.14
-0.08
-0.11
-0.07
Interest and investment income
309.00K
386.00K
355.00K
252.00K
Interest expense
-1.16M
-
-
-
Net interest expenses
-850.00K
386.00K
355.00K
252.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.41M
-16.86M
-34.56M
-24.01M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer